Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 19, 1999, Pages 2795-2800

  Choi, Kyung Il ^a   Cha, Joo Hwan ^a   Cho, Yong Seo ^a   Pae, Ae Nim ^a   Jin, Changbae ^a   Yook, Juwon ^a   Cheon, Hyae Gyeong ^b   Jeong, Daeyoung ^b   Kong, Jae Yang ^b   Koh, Hun Yeong ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1 AZABICYCLO[2.2.1]HEPTAN 3 ONE O [3 (3' METHOXYPHENYL) 2 PROPYNYL]OXIME MALEATE; 3 (3 PHENYLISOXAZOL 5 YL)METHYLIDENE 1 AZABICYCLE; BICYCLO COMPOUND; CHOLINERGIC RECEPTOR; CYTISINE; KETONE; KST 5452; METHYLSCOPOLAMINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; NICOTINIC AGENT; NICOTINIC RECEPTOR; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; COLUMN CHROMATOGRAPHY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; RACEMIC MIXTURE; STEREOCHEMISTRY;

ALKALOIDS; AZA COMPOUNDS; AZOCINES; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; ISOXAZOLES; MOLECULAR STRUCTURE; N-METHYLSCOPOLAMINE; PROTEIN BINDING; QUINOLIZINES; RECEPTORS, CHOLINERGIC; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC;

EID: 0033523641     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00477-1     Document Type: Article

References (11)

1. 1. Fuse, Y.; Yamamoto, K.; Kishida, H.; Miwa, T.; Hidaka, T.; Katsumi, I. WO 19,348, 1994; Chem. Abstr. 1994, 121, 280563.
2. 2. Tecle, H.; Barrett, S. D.; Lauffer, D. J.; Augelli-Szafran, C.; Brann, M. R.; Callahan, M. J.; Caprathe, B. W.; Davis, R. E.; Doyle, P. D.; Eubanks, D.; Lipiniski, W.; Mirzadegan, T.; Moos, W. H.; Moreland, D. W.; Nelson, C. B.; Pavia, M. R.; Raby, C.; Schwarz, R. D.; Spencer, C. J.; Thomas, A. J.; Jaen, J. C. J. Med. Chem. 1998, 41, 2524.
3. 3. Olesen, P. H.; Swedberg, M. D. B.; Eskesen, K.; Judge, M. E.; Egebjerg, J.; Tønder, J. E.; Rasmussen, T.; Sheardown, M. J.; Rimvall, K. Bioorg. Med. Chem. Lett. 1997, 7, 1963.
4. 4. Street, L. J.; Baker, R.; Book, T.; Kneen, C. O.; MacLeod, A. M.; Merchant, K. J.; Showell, G. A.; Saunders, J.; Herbert, R. H.; Freedman, S. B.; Harley, E. A. J. Med. Chem. 1990, 33, 2690.
5. 3 (M + H) 403.2021, found 403.2015.
6. 11 with minor modifications. After the addition of the membrane fraction containing approximately 300 μg of protein followed by incubation at 4 °C for 75 min, the reaction mixture was analyzed by a conventional filtration assay method.
7. 7. Dehaven-hudkins, D. L.; Stubbins, J. F.; Hudkins, R. L. Eur. J. Pharmacol. 1993, 231, 485.
8. 8. Yang, C. M.; Yeh, H. M.; Sung, T. C.; Chen, F. F.; Wang, Y. Y. J. Recep. Res. 1992, 12, 427.
9. 9. Ringdahl, B. J. Pharmacol. Exp. Ther. 1984, 229, 199.
10. 10. Lin, N.-H.; Carrera, G. M. Jr.; Anderson, D.J. J. Med Chem. 1994, 37, 3542.
11. 11. Zukin, S. R.; Young, A. B.; Snyder, S. H. Proc. Nat. Acad. Sci. (USA), 1974, 71, 4802.